(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.31%) $0.929
(-1.07%) $10.87
(-0.13%) $0.797
(0.35%) $91.45
1.22% $ 21.50
@ $25.17
Emitido: 14 feb 2024 @ 09:30
Retorno: -14.58%
Señal anterior: feb 13 - 09:31
Señal anterior:
Retorno: -0.59 %
Live Chart Being Loaded With Signals
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 355 667 |
Volumen promedio | 216 209 |
Capitalización de mercado | 640.37M |
EPS | $0 ( 2024-05-03 ) |
Próxima fecha de ganancias | ( $-0.320 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.82 |
ATR14 | $0.0290 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Hsieh Ming | Sell | 1 337 | Common Stock |
2024-04-30 | Gao Hanlin | Sell | 79 | Common Stock |
2024-04-26 | Xie Jian | Sell | 4 344 | Common Stock |
2024-04-26 | Kim Paul | Sell | 2 738 | Common Stock |
2024-04-26 | Gao Hanlin | Sell | 1 154 | Common Stock |
INSIDER POWER |
---|
1.33 |
Last 99 transactions |
Buy: 2 001 398 | Sell: 1 963 075 |
Volumen Correlación
Fulgent Genetics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
SSTI | 0.962 |
FWRD | 0.958 |
PACB | 0.958 |
CCSI | 0.958 |
RIVN | 0.956 |
WW | 0.954 |
NVTS | 0.953 |
ESCA | 0.952 |
APPS | 0.951 |
GP | 0.951 |
10 Correlaciones Más Negativas | |
---|---|
GXII | -0.966 |
DXJS | -0.963 |
MSAC | -0.961 |
AGGR | -0.959 |
HERA | -0.957 |
AEAC | -0.956 |
TBSAU | -0.956 |
CRZN | -0.955 |
ABGI | -0.955 |
HERAU | -0.955 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fulgent Genetics Inc Correlación - Moneda/Commodity
Fulgent Genetics Inc Finanzas
Annual | 2023 |
Ingresos: | $289.21M |
Beneficio Bruto: | $96.61M (33.40 %) |
EPS: | $-5.63 |
FY | 2023 |
Ingresos: | $289.21M |
Beneficio Bruto: | $96.61M (33.40 %) |
EPS: | $-5.63 |
FY | 2022 |
Ingresos: | $618.97M |
Beneficio Bruto: | $366.90M (59.28 %) |
EPS: | $4.76 |
FY | 2021 |
Ingresos: | $992.58M |
Beneficio Bruto: | $777.05M (78.29 %) |
EPS: | $17.25 |
Financial Reports:
No articles found.
Fulgent Genetics Inc
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico